Clene Inc. Long-Term Debt, Maturity, Remainder of Fiscal Year
Clene Inc. (CLNN) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $187.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2026-08-14
- 2026-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $187.00K.
- 2026-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $797.00K.
- 2025-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $89.00K.
- 2025-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $176.00K.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $187.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $797.00K 10-Q · filed 2026-05-14 |
| 2025-09-30 | $89.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $176.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $347.00K 10-Q · filed 2025-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |